Inhibition of selenite-induced cytotoxicity and apoptosis in human colonic carcinoma (HT-29) cells by copper

Nutrition and Cancer

Volumn 32, Issue 3, 1998, Pages 181-189

  Davis, Randall L ^a   Spallholz, Julian E ^b   Pence, Barbara C ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER SULFATE; GLUTATHIONE; SELENITE; SUPEROXIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL;

EID: 0032462178     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589809514738     Document Type: Article

References (41)

1. El-Bayoumy, K: The role of selenium in cancer prevention. In Cancer Principles and Practice of Oncology, 4th ed. Philadelphia, PA: Lippincott, 1991, pp 1-15.
2. Spallholz, JE: On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med 17, 45-64, 1994.
3. Clark, LC, Combs, GF, Turnbull, BW, Slate, EH, Chalker, DK, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA 276, 1957-1963, 1996.
4. Siwek, B, Bahbouth, E, Serra, MA, Sabbioni, E, de Pauw-Gillet, MC, et al.: Effect of selenium compounds on murine B16 melanoma cells and pigmented cloned pB16 cells. Arch Toxicol 68, 246-254, 1994.
5. Thompson, HJ, Wilson, A, Lu, J, Singh, M, Jiang, C, et al.: Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 15, 183-186, 1994.
6. Spyrou, G, Bjornstedt, M, Skog, S, and Holmgren, A: Selenite and selenate inhibit human lymphocyte growth via different mechanisms. Cancer Res 56, 4407-4412, 1996.
7. Poirier, KA, and Milner, JA: Factors influencing the antitumorigenic properties of selenium in mice. J Nutr 113, 2147-2154, 1983.
8. Zhang, ZH, Kimura, M, and Itokawa, Y: Inhibitory effect of selenium and change of glutathione peroxidase activity on rat glioma. Biol Trace Elem Res 55, 31-38, 1996.
9. Comstock, GW, Bush, TL, and Helzlsouer, K: Serum retinol, β-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 135, 115-121, 1992.
10. Schrauzer, GN: Selenium: mechanistic aspects of anticarcinogenic action. Biol Trace Elem Res 33, 51-62, 1992.
11. Wilson, AC, Thompson, HJ, Schedin, PJ, Gibson, NW, and Ganther, HE: Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage. Biochem Pharmacol 43, 1137-1141, 1992.
12. Redman, C, Xu, MJ, Peng, YM, Scott, JA, Payne, C, et al.: Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis 18, 1195-1202, 1997.
13. Zhu, Z, Kimura, M, Itokawa, Y, Aoki, T, Takahashi, JA, et al.: Apoptosis induced by selenium in human glioma cell lines. Biol Trace Elem Res 54, 123-134, 1996.
14. Nelson, KK, Bacon, B, and Christensen, MJ: Selenite supplementation decreases expression of MAZ in HT29 human colon adenocarcinoma cells. Nutr Cancer 26, 73-81, 1996.
15. Kiremidjian-Schumacher, L, Roy, M, Wishe, HI, Cohen, MW, and Stotzky, G: Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 41, 115-127, 1994.
16. Lu, J, Kaek, M, Jiang, C, Wilson, AC, and Thompson, HJ: Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol 47, 1531-1535, 1994.
17. Sarafian, TA, and Bredesen, DE: Invited commentary: is apoptosis mediated by reactive oxygen species? Free Radic Res 21, 1-8, 1994.
18. Farber, JL: Mechanisms of cell injury by activated oxygen species. Environ Health Perspect 102, Suppl 10, 17-24, 1994.
19. Seko, Y, Saito, Y, Kitahara, J, and Imura, N: Active oxygen generation by the reaction of selenite with reduced glutathione in vitro. In Selenium in Biology and Medicine, A Wendel (ed). Berlin: Springer-Verlag, 1989, pp 70-73.
20. Davis, RL, and Spallholz, JE: Inhibition of selenite-catalyzed superoxide generation and formation of elemental selenium (Se°) by copper, zinc and aurintricarboxylic acid (ATA). Biochem Pharmacol 51, 1015-1020, 1996.
21. Hissin, PJ, and Hilf, R: A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74, 214-226, 1976.
22. Chozick, BS, Eva-Weicker, M, Pezzullo, JC, Jackson, CL, Finkelstein, SD, et al.: Pattern of mutant p53 expression in human astrocytomas suggest the existence of alternate pathways of tumorigenesis. Cancer 73, 406-415, 1994.
23. Sigma Stat 1.0. San Rafael, CA: Jandel Scientific, 1992.
24. Yan, L, and Frenkel, GD: Inhibition of cell attachment by selenite. Cancer Res 52, 5803-5807, 1992.
25. Hill, CH: Reversal of selenium toxicity in chicks by mercury, copper and cadmium. J Nutr 104, 593-598, 1974.
26. Berry, JP, Dennebouy, R, Chaintreau, M, Dantin, F, Slodzian, G, et al.: Scanning ion microscopy mapping of basement membrane elements and arterioles in the kidney after selenium-silver interaction. Cell Mol Biol 41, 265-270, 1995.
27. Kitahara, J, Seko, Y, and Imura, N: Possible involvement of active oxygen species in selenite toxicity in isolated rat hepatocytes. Arch Toxicol 67, 497-501, 1993.
28. Yan, L, and Spallholz, JE: Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem Pharmacol 45, 429-437, 1993.
29. Lengfelder, E, Fuchs, C, Younes, M, and Weser, W: Functional aspects of the superoxide dismutative action of Cu-penicillamine. Biochim Biophys Acta 576, 492-502, 1979.
30. Darr, DJ, Yanni, S, and Pinnell, SR: Protection of Chinese hamster ovary cells from paraquat-mediated cytotoxicity by low molecular weight mimic of superoxide dismutase (DF-Mn). Free Radic Biol Med 4, 357-363, 1988.
31. Rabinovich, HD, Rosen, GM, and Fridovich, I: A mimic of superoxide dismutase activity protects Chlorella sorokiniana against the toxicity of sulfite. Free Radic Biol Med 6, 45-48, 1989.
32. Hu, ML, and Spallholz, JE: In vitro hemolysis of rat erythrocytes by selenium compounds. Biochem Pharmacol 32, 957-961, 1983.
33. Batist, G, Katki, AG, Klecker, RW, Jr, and Myers, CE: Selenium-induced cytotoxicity of human leukemia cells: interaction with reduced glutathione. Cancer Res 46, 5482-5485, 1986.
34. Yan, L, Yee, JA, Boylan, LM, and Spallholz, JE: Effect of selenium compounds and thiols on human mammary tumor cells. Biol Trace Elem Res 30, 145-162, 1991.
35. Stewart, MS, Davis, RL, Walsh, LP, and Pence, BC: Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29). Cancer Lett 117, 35-40, 1997.
36. Kuchan, MJ, and Milner, JA: Influence of intracellular glutathione on selenite-mediated growth inhibition of canine mammary tumor cells. Cancer Res 52, 1091-1095, 1992.
37. Bellamy, COC, Malcomson, RDG, Harrison, DG, and Wyllie, AH: Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol 6, 3-16, 1995.
38. Bedi, A, Pasricha, PJ, Akhtar, AJ, Barber, JP, Bedi, GC, et al.: Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55, 1811-1816, 1995.
39. Thompson, HJ, Wilson, A, Lu, J, Singh, M, Jiang, C, et al.: Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 15, 183-186, 1994.
40. Lanfear, J, Fleming, J, Wu, L, Webster, G, and Harrison, PR: The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 15, 1387-1392, 1994.
41. Lu, J, Jiang, C, Kaeck, M, Ganther, H, Vadhanavikit, S, et al.: Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol 50, 213-219, 1995.